Nelson Vergel, the founder of ExcelMale.com, ClinicOptimizers.com and DiscountedLabs.com, interviews Dr. Richard Walker about the history of research on GHRH and GHRPs.
Richard F. Walker, Ph.D., R.Ph is well known for having popularized Sermorelin, a growth hormone-releasing hormone. He received a BS in pharmacy from Rutgers University, an MS in biochemistry from New Mexico State University and a Ph.D. in physiology from Rutgers University. He completed an internship in neuroanatomy/electrophysiology at Emory University College of Medicine, and postdoctoral fellowships in neuroendocrinology and neuropharmacology at Duke University College of Medicine (Center for the Study of Aging and Human Development) and the University of California, Berkeley, respectively. Dr. Walker held tenured faculty positions at Clemson University (Department of Zoology) and the University of Kentucky, College of Medicine (Department of Anatomy and Molecular Biology/Sanders-Brown Research Center on Aging). He left academia for a brief hiatus in the pharmaceutical industry serving as Director of Toxicology at SmithKline Beecham Pharmaceutical Corp. At the same time, he was also a research professor in the Department of Pharmacology at the Medical College of Pennsylvania and later at the University of South Florida (USF) College of Medicine. In addition to his research duties at USF, Walker served as Director for Research Compliance and also Director of USF CARES (Clinical Alliance for Research, Education, and Service). He has been the recipient of many federal (NSF, NIH, DOD), state and local research grants and has published extensively towards understanding the cause of senescence and treating functional deficits associated with organismal aging. Walker is currently Editor-in-Chief of Clinical Interventions in Aging, a source of evidence-based information for practitioners of age-management medicine published by Dove Medical Press and author of the book, “Why We Age: Insight into the cause of growing old” He is partner in ProSoma LLC which manufactures and distributes anti-aging products, and he also heads a private consulting company offering regulatory and scientific services to physicians and other health-care professionals.
Recent Posts
Is Metformin a Miracle Drug ? : Nelson Vergel Explains
Jay Campbell invited me to present a review of relevant data on the use of Metformin in men with and without diabetes. I hope...
Video: Testosterone Replacement Options
In theory testosterone replacement should approximate the body’s own natural production of the hormone. The average male produces 4 to 7 mg of testosterone...
Dr. Saya Speaks About HRT
This is a short video in which Dr. Justin Saya from DefyMedical.com speaks about his approach for hormone replacement therapy in women.
Statin Drugs Markedly Inhibit Testosterone Production in Rats: Implications for Men
Statin Drugs Markedly Inhibit Testosterone Production by Rat Leydig Cells in Vitro: Implications for Men
Reproductive Toxicology
Highlights
•Statins cause significant reductions in LH-stimulated testosterone production by...
Fatigue- When Testosterone Is Not Enough
Taken from the book: Testosterone: A Man’s Guide by Nelson Vergel
If no improvements in fatigue are observed after 6 weeks of testosterone replacement, factors...